ALB vs. WST

Last updated Apr 1, 2026

Compare and contrast key facts about Albemarle Corporation (ALB) and West Pharmaceutical Services, Inc. (WST).

Performance

ALB vs. WST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Albemarle Corporation (ALB) and West Pharmaceutical Services, Inc. (WST). The values are adjusted to include any dividend payments, if applicable.

ALB vs. WST - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ALB Albemarle Corporation	27.24%	67.72%	-39.50%	-32.80%	-6.63%	59.76%	105.39%	-3.28%	-38.89%	50.22%
WST West Pharmaceutical Services, Inc.	-8.82%	-15.73%	-6.75%	49.97%	-49.70%	65.88%	89.05%	54.13%	-0.08%	17.02%

Fundamentals

Market Cap ALB : $21.13B WST : $18.22B
EPS ALB : -$4.69 WST : $6.79
PS Ratio ALB : 4.11 WST : 5.93
PB Ratio ALB : 2.90 WST : 5.74
Total Revenue (TTM) ALB : $5.14B WST : $3.07B
Gross Profit (TTM) ALB : $668.72M WST : $1.10B
EBITDA (TTM) ALB : $221.01M WST : $723.60M

Returns By Period

In the year-to-date period, ALB achieves a 27.24% return, which is significantly higher than WST's -8.82% return. Over the past 10 years, ALB has underperformed WST with an annualized return of 12.16%, while WST has yielded a comparatively higher 13.95% annualized return.

ALB

• 1D: 1.30%
• 1M: 0.73%
• YTD: 27.24%
• 6M: 122.64%
• 1Y: 153.65%
• 3Y*: -5.28%
• 5Y*: 4.79%
• 10Y*: 12.16%

WST

• 1D: 2.24%
• 1M: -1.45%
• YTD: -8.82%
• 6M: -4.29%
• 1Y: 12.35%
• 3Y*: -9.99%
• 5Y*: -2.27%
• 10Y*: 13.95%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ALB vs. WST — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALB

ALB Risk / Return Rank: 91
ALB Sharpe Ratio Rank: 94
ALB Sortino Ratio Rank: 88
ALB Omega Ratio Rank: 87
ALB Calmar Ratio Rank: 94
ALB Martin Ratio Rank: 93

WST

WST Risk / Return Rank: 53
WST Sharpe Ratio Rank: 54
WST Sortino Ratio Rank: 52
WST Omega Ratio Rank: 50
WST Calmar Ratio Rank: 55
WST Martin Ratio Rank: 55

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ALB vs. WST - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Albemarle Corporation (ALB) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ALB	WST	Difference
Sharpe ratio Return per unit of total volatility	2.39	0.30	+2.09
Sortino ratio Return per unit of downside risk	2.63	0.83	+1.80
Omega ratio Gain probability vs. loss probability	1.35	1.10	+0.25
Calmar ratio Return relative to maximum drawdown	5.15	0.53	+4.61
Martin ratio Return relative to average drawdown	12.66	1.10	+11.57
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ALB vs. WST - Sharpe Ratio Comparison

The current ALB Sharpe Ratio is 2.39, which is higher than the WST Sharpe Ratio of 0.30. The chart below compares the historical Sharpe Ratios of ALB and WST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ALB	WST	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.39	0.30	+2.09
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.09	-0.06	+0.15
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.26	0.41	-0.15
Sharpe Ratio (All Time) Calculated using the full available price history	0.31	0.37	-0.06

Correlation

The correlation between ALB and WST is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ALB vs. WST - Dividend Comparison

ALB's dividend yield for the trailing twelve months is around 0.90%, more than WST's 0.34% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ALB Albemarle Corporation	0.90%	1.15%	1.87%	1.11%	0.73%	0.67%	1.04%	2.01%	1.74%	1.00%	1.42%	2.07%
WST West Pharmaceutical Services, Inc.	0.34%	0.31%	0.25%	0.22%	0.31%	0.15%	0.23%	0.41%	0.58%	0.54%	0.58%	0.75%

Drawdowns

ALB vs. WST - Drawdown Comparison

The maximum ALB drawdown since its inception was -83.90%, which is greater than WST's maximum drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for ALB and WST.

Drawdown Indicators

	ALB	WST	Difference
Max Drawdown Largest peak-to-trough decline	-83.90%	-59.29%	-24.61%
Max Drawdown (1Y) Largest decline over 1 year	-29.74%	-24.70%	-5.04%
Max Drawdown (5Y) Largest decline over 5 years	-83.90%	-59.29%	-24.61%
Max Drawdown (10Y) Largest decline over 10 years	-83.90%	-59.29%	-24.61%
Current Drawdown Current decline from peak	-42.07%	-46.22%	+4.15%
Average Drawdown Average peak-to-trough decline	-20.55%	-16.79%	-3.76%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.09%	12.05%	+0.04%

Volatility

ALB vs. WST - Volatility Comparison

Albemarle Corporation (ALB) has a higher volatility of 16.32% compared to West Pharmaceutical Services, Inc. (WST) at 9.11%. This indicates that ALB's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ALB	WST	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.32%	9.11%	+7.21%
Volatility (6M) Calculated over the trailing 6-month period	43.64%	24.91%	+18.73%
Volatility (1Y) Calculated over the trailing 1-year period	64.79%	41.43%	+23.36%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	53.87%	40.04%	+13.83%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	47.65%	34.28%	+13.37%

Financials

ALB vs. WST - Profitability Comparison

The chart below illustrates the profitability comparison between Albemarle Corporation and West Pharmaceutical Services, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ALB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Albemarle Corporation reported a gross profit of 197.93M and revenue of 1.43B. Therefore, the gross margin over that period was 13.9%.

WST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported a gross profit of 303.90M and revenue of 805.00M. Therefore, the gross margin over that period was 37.8%.

ALB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Albemarle Corporation reported an operating income of -217.39M and revenue of 1.43B, resulting in an operating margin of -15.2%.

WST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported an operating income of 157.10M and revenue of 805.00M, resulting in an operating margin of 19.5%.

ALB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Albemarle Corporation reported a net income of -455.87M and revenue of 1.43B, resulting in a net margin of -31.9%.

WST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, West Pharmaceutical Services, Inc. reported a net income of 132.10M and revenue of 805.00M, resulting in a net margin of 16.4%.